The GLP-1 drugs, like Ozempic and Wegovy, are hailed as a public health triumph, but a potential side effect may be causing marital tension. A study reveals that as weight drops, the risk of divorce increases, and this trend is particularly notable among bariatric surgery patients. Professor Svensson, an expert in the field, warns that the social fallout of these drugs is real and can lead to relationship dynamics changing. Svensson explains that the weight loss process unfolds in stages, starting with substantial weight loss within the first year, followed by changes in relationship dynamics and potentially divorce. This aligns with previous studies showing that bariatric surgery patients are twice as likely to get divorced compared to the general population. While GLP-1 drugs offer metabolic benefits, Svensson suggests that the psychological and social shifts accompanying weight loss may be the real cause of marital splits. Many patients report increased social engagement and attention from others post-weight loss, which can strain relationships if a partner struggles to adapt. A 2013 study supports this theory, finding that significant weight loss in one partner can lead to feelings of insecurity and criticism from the other. Svensson emphasizes that weight loss doesn't have to mean relationship loss, and single individuals may even benefit from increased relationship opportunities. To mitigate marital risks, Svensson recommends a collaborative approach to health, involving partners in healthy lifestyle changes. This shared journey can strengthen the bond between couples, provided both have a clinical need for weight-loss treatment. The article concludes by highlighting the importance of understanding the psychological and social impacts of weight loss on relationships, especially as more people turn to GLP-1 drugs for health improvements.
